Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.5.5 appears to replace v3.5.4 in the page metadata, signaling a small update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-05T09:52:06.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.5.4) replacing v3.5.3, indicating a small site update. This change affects metadata rather than any study details.
    Difference
    0.1%
    Check dated 2026-05-15T05:38:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov site software.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:11.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Updated the site's release label from Revision: v3.5.0 to Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T12:26:59.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added: Revision v3.5.0; Removed: Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:25:09.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T20:11:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.